.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Johnson and Johnson
Medtronic
McKesson
Queensland Health
Daiichi Sankyo
McKinsey
Fuji
Baxter
Federal Trade Commission

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,912,268

« Back to Dashboard

Summary for Patent: 5,912,268

Title: Dosage form and method for treating incontinence
Abstract:A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
Inventor(s): Guittard; George V. (Cupertino, CA), Jao; Francisco (San Jose, CA), Marks; Susan M. (San Jose, CA), Kidney; David J. (Palo Alto, CA), Gumucio; Fernando E. (Santa Clara, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Application Number:08/806,773
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Delivery; Composition;

No matches for this query

International Patent Family for Patent: 5,912,268

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2218714► Subscribe
Canada2510391► Subscribe
Switzerland690955► Subscribe
Germany19681389► Subscribe
United Kingdom9723081► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Julphar
Queensland Health
Merck
Daiichi Sankyo
UBS
Federal Trade Commission
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot